Saudi health innovators accelerate smart health impact with KAUST’s experience

Summary

Saudi health innovators are increasing investment in smart health solutions, using KAUST's infrastructure and expertise. The King Salman Center for Disability Research (KSCDR) and KCSH are partnering on AI-based methods to identify genetic causes of rare eye diseases. KAUST and the Saudi Food and Drug Administration (SFDA) are expanding their agreement to enhance cooperation on AI and digital innovation. Why it matters: These partnerships signal a concerted effort to leverage AI for addressing critical healthcare challenges and advancing the Kingdom's health priorities.